Current and Emerging Treatment Options in Colorectal Cancer
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Gastroenterology & Hepatopancreatobiliary Medicine".
Deadline for manuscript submissions: 30 December 2025 | Viewed by 15
Special Issue Editor
Special Issue Information
Dear Colleagues,
Colorectal cancer (CRC) remains a major global health challenge, requiring innovative treatment strategies to enhance patient outcomes and improve quality of life. For this Special Issue, we invite original research articles, reviews, and perspectives focusing on current and emerging treatment options for CRC. We welcome contributions addressing topics such as advancements in chemotherapy, immunotherapy, and targeted therapies, as well as the development of combination treatments. Submissions exploring the molecular mechanisms driving CRC progression, novel biomarkers for diagnosis or therapeutic response prediction, and the application of precision medicine are particularly encouraged. Additionally, we invite research on new technologies in CRC surgery, including robotic-assisted procedures, minimally invasive techniques, and intraoperative imaging tools. Studies including clinical trial outcomes, challenges in treatment delivery, and strategies to overcome drug resistance are also within our scope. However, mini-reviews and case reports will not be considered. This Special Issue will advance CRC treatment and foster interdisciplinary collaboration in research and clinical practice.
Dr. Michael Osseis
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- colorectal cancer (CRC)
- emerging treatment options
- targeted therapies
- new surgical technologies
- precision medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
